Nuclear medicine production at ANSTO
Media statement from ANSTO.
Showing 521 - 540 of 688 results
Media statement from ANSTO.
X-ray crystallography at the Australian Synchrotron contributed to major research findings.
Osteoporosis is a major public health issue, and it has been estimated that total annual cost of osteoporosis/osteopenia in Australia is around $2,754 million.
ANSTO Head of Research Dr Suzanne Hollins has been appointed to chair IAEA group on nuclear applications.
The Imaging and Medical beamline (IMBL) is a flagship beamline of the Australian Synchrotron built with considerable support from the NHMRC. It is one of only a few of its type, and delivers the world’s widest synchrotron x-ray ‘beam’.
ANSTO's Melbourne location is home to the ANSTO-owned and operated Australian Synchrotron. The Synchrotron is one of the Australia's most significant pieces of scientific infrastructure.
Best and brightest recognised in 2017 research awards
Guidance for obtaining and maintaining human or animal ethics approval at the Australian Synchrotron.
The Graduate Institute is part of ANSTO’s Innovation Precinct and links all graduates together to create a network of Australia’s brightest young minds focused on the future.
Lutetium-177 used for advanced prostate cancer